creative commons

Pfizer has decided not to make a takeover offer for AstraZeneca.

And that has state Delaware state officials expressing relief that AstraZeneca’s thousands of jobs in the state will be untouched.

The announcement yesterday came after the AstraZeneca rejected the proposed purchase price of $119 billion from Pfizer, the world’s second largest drug manufacturer.

The Wilmington News Journal reports that under British law Pfizer cannot make another bid for another six months but with one exception -- it can do so as soon as 90 days if AstraZeneca invites another offer.

official photo

Senator Chris Coons has called on the Federal Trade Commission and the Justice Department to review the proposed acquisition of the British based AstraZeneca by Pfizer for a potential anti-trust violation.

The Delaware Democrat wrote in his letter to the agencies that Pfizer has a history of acquiring drug companies and slashing jobs.

He charged that the acquisition could lead to fewer drugs and have adverse effects on the consumer.

If the acquisition goes through Pfizer could reincorporate in the United Kingdom with a tax savings of $1 billion.

Pfizer website

DOVER, Del. (AP) - The CEO of drugmaker Pfizer Inc. is telling the governors of Delaware and Maryland that it's premature to speculate about the potential jobs impact of a merger with British rival AstraZeneca PLC.

Govs. Jack Markell of Delaware and Martin O'Malley of Maryland sent a joint letter to Pfizer chief Ian Read last week expressing concerns about the possible acquisition of AstraZeneca. The company employs some 2,600 people in Delaware and 3,100 in Maryland.

astrazeneca logo

ANNAPOLIS, Md. (AP) - The governors of Maryland and Delaware are voicing concern about Pfizer Inc.'s efforts to acquire AstraZeneca PLC.

Maryland Gov. Martin O'Malley and Delaware Gov. Jack Markell sent a letter on Thursday to Ian Read, the chief executive officer of Pfizer

The two governors say they are concerned about the potential impact such a deal could have on jobs in Maryland and Delaware. AstraZeneca employs about 3,100 people in Maryland and about 2,600 in Delaware.

O'Malley and Markell also sent letters to several federal officials in the United States.